Company Presentation

Endogena Therapeutics is a clinical-stage biotechnology company that discovers and develops first-in-class endogenous regenerative medicines to repair diseased tissues. Our unique approach has the potential for a paradigm shift in how degenerative conditions due to aging and genetic disorders are treated. This most advanced programs target degenerative diseases of the eye, including retinitis pigmentosa and geographic atrophy (secondary to AMD).